Research will be integrated into all aspects of departmental practice -- stimulating ideas for project development, serving as a medium for specimen collection/storage and as a conduit for translational studies. Our research programs are dedicated to one specific goal – finding means to improve both the quality and quantity of life for patients with diseases affecting the ears, nose and throat.
Select a faculty member to learn more about their research efforts:
All PGY-3 residents have a dedicated research block of either four or six months. This research block is fully dedicated time without clinical responsibilities or night call. Planning for the research experience starts in the PGY-2 year with the choice of a mentor followed by preparation of an abstract and budget for the project by mid-April. The research can be within the departmental laboratories or within other departments including Anatomy, Environmental Toxicology, Oncology, Radiation Oncology, and Molecular Biology laboratories within the Dental School.
Our Otolaryngology program has strong ties with the National Institutes of Health, and residents may choose to perform their research with a pre-approved mentor from the NIH. In the past three years, two of our residents, Katherine Day, M.D., and Hao Tran, M.D., won the top resident research award in the country for projects done during their research rotation.
In the past year, our residents published three papers in peer-reviewed medical journals, and our residents made presentations of these papers at national meetings. This is a measure of the quality of research opportunities and mentorship provided in our program.
Plans are in place for significant growth in the Oto-HNS research program. The Department is currently interviewing candidates for a Ph.D. immunologist/tumor biologist, with an emphasis on translational research. This faculty recruitment is a coordinated effort with Dr. Kevin Cullen (Cancer Center Director) and Dr. Stephen Bartlett (Surgery Chair).
In addition, the Department is recruiting a senior neurotologic researcher with a research interest in either gene therapy (as a means for gene delivery to the auditory system) or the genetic causes underlying sensorineural hearing loss. It is anticipated that this individual will collaborate with Dr. Staecker and promote new areas of research growth.
Finally, Dr. Strome will assist Drs. Taylor, Wolf and Le in the development of their research programs and has dedicated space within his laboratory to promote their academic career.